Therapeutic compliance in patients with arterial hypertension and type 2 diabetes mellitus

被引:20
|
作者
Gutierrez-Angulo, M. L. [1 ]
Lopetegi-Uranga, P. [1 ]
Sanchez-Martin, I. [1 ]
Garaigordobil-Landazabal, M. [2 ]
机构
[1] Ctr Salud Renteria Beraun, Comarca Ekialde Guipuzcoa Osakidetza, Serv Vasco Salud, Renteria Beraun, Guipuzcoa, Spain
[2] Univ Basque Country, Fac Psicol, Dept Personalidad Evaluac & Tratamientos Psicol, San Sebastian, Guipuzcoa, Spain
关键词
Medication adherence; Non-adherence; Compliance; Hypertension; Diabetes;
D O I
10.1016/j.cali.2011.09.008
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: 1) To determine gender differences regarding therapeutic adherence in patients with arterial hypertension and type 2 diabetes mellitus. 2) To detect differences in terms of age. 3) To determine existing relationships in patient compliance levels between Morisky-Green's test, Batalla's test and the pill count expressed as a percentage of compliance. Method: Descriptive, transversal study, carried out for a period of 7 months in the Primary Health Care, Health Centre in Renteria-Beraun (Guipuzcoa), Basque Health Service (Osakidetza), with an incidental sample of 100 patients diagnosed with hypertension and type 2 diabetes mellitus and receiving oral treatment. Principal variables: age, gender. Conditioning variables: years of evolution of each pathology, number of prescribed medicines, time lapse of prescription collection, Morisky-Green's test, Batalla's test and pill count. Results: The statistical analysis yielded similar compliance for men and women, and for different age groups (Morisky-Green and pill count). Approximately 50% of the patients had adequate compliance according to at least one of the 3 tests. A greater relationship was found between Morisky-Green's test and the pill count method, and medication adherence improved when knowledge of the disease increased, and when the number of prescribed pills became smaller. Conclusions: Adherence varies according to the evaluation tool used, non-adherence is high and knowledge of the disease helps compliance. This suggests the convenience of systematically reviewing treatments and supplying more information to patients. (C) 2011 SECA. Published by Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:72 / 77
页数:6
相关论文
共 50 条
  • [21] CEREBROPROTECTIVE PROPERITES OF NEBIVALOL IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH TYPE 2 DIABETES MELLITUS
    Zahidova, K.
    Guliyev, F.
    [J]. JOURNAL OF HYPERTENSION, 2010, 28 : E454 - E454
  • [22] Activity Of Aggregation Properties Of Neutrophils In Patients With Arterial Hypertension With Type 2 Diabetes Mellitus
    Medvedev, I. N.
    [J]. RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2018, 9 (05): : 2043 - 2047
  • [23] Clinical-Epidemiological Features of Arterial Hypertension in Patients With Type 2 Diabetes Mellitus
    Mehdiev, S. Kh.
    Mustafaev, I. I.
    Mamedov, M. N.
    Deev, A. D.
    [J]. KARDIOLOGIYA, 2016, 56 (11) : 43 - 49
  • [24] Functional features of microcirculation in patients with type 2 diabetes mellitus with concomitant arterial hypertension
    Rudenko, E., V
    [J]. DIABETES MELLITUS, 2008, 11 (01): : 28 - 29
  • [25] Expression Of Spontaneous Aggregation Of Erythrocytes In Patients With Arterial Hypertension With Type 2 Diabetes Mellitus
    Medvedev, I. N.
    [J]. RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2018, 9 (05): : 1448 - 1452
  • [26] THE EFFICACY OF COMBITATION OF EMPAGLIFLOZIN AND METFORMIN IN PATIENTS WITH ARTERIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS
    Zhuravlyova, Larysa
    Filonenko, Maryna
    Rogachova, Tetyana
    Sokolnikova, Nelly
    [J]. JOURNAL OF HYPERTENSION, 2023, 41 : E194 - E194
  • [27] FUNCTIONAL CONDITION OF KIDNEYS IN PATIENTS WITH ARTERIAL HYPERTENSION IN COMBINATION WITH TYPE 2 DIABETES MELLITUS
    Bilovol, O. M.
    Kniazkova, I. I.
    Kirienko, O. M.
    Kuzminova, N. V.
    Golovachova, V. O.
    Kirienko, D. O.
    Abramova, L. P.
    [J]. WORLD OF MEDICINE AND BIOLOGY, 2022, 80 (02): : 24 - 29
  • [28] Valsartan in patients with arterial hypertension and type 2 diabetes mellitus.: The lapaval study
    Pérez, JCR
    Novoa, JN
    Caballero, A
    Anabitarte, A
    Plaza, C
    Palop, L
    Esparragón, FR
    [J]. NEFROLOGIA, 2005, 25 (05): : 500 - 508
  • [29] Effect of enoxaparin on brain perfusion in patients with type 2 diabetes mellitus and arterial hypertension
    Mychka, V
    Chazova, I
    Mamyrbaeva, K
    Gornostaev, V
    Sergienko, V
    [J]. JOURNAL OF HYPERTENSION, 2005, 23 : S127 - S127
  • [30] Arterial hypertension and type 1 diabetes mellitus
    Uruski, Pawel
    Uruska, Aleksandra
    Zozulinska, Dorota
    Tykarski, Andrzej
    [J]. ARTERIAL HYPERTENSION, 2007, 11 (02): : 85 - 94